SBHSally Beauty Holdings, Inc.

$17.41+18% 1Y

Is the price fair?

Good

Undemanding: modest expectations priced in and cheap vs its sector.

2 good, 1 neutral
What the price assumes~−9% a year

Priced for a decline (~−9% a year). Little growth is priced in even as revenue fell 0% a year over three years, potential value, or a value trap.

Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 9.1 vs a 8.5 median over 41 quarters (+7% vs median).

Vs sector (EV/EBIT)7.2×

Sector median 15.0× across 156 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Unless marked, from derived, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)top 7% of the market
FCF yieldtop 6% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What SBH's price assumes

Sally Beauty Holdings, Inc. trades at 9.07× earnings against 22.8× for the median Specialty Retail name, cheaper than its own group.

9.07

Trailing P/E · Specialty Retail median 22.8 · cheaper than the typical name in its group

Price / sales
0.44

Price / sales · today's price, trailing year to Jun 30, 2026

Free cash flow yield
15%

Free cash flow yield · Specialty Retail median 5.5%

Growth the price implies
−9.1%

Growth the price implies · The price pays for −9.1% free cash flow growth a year for a decade; the business has delivered +19% a year over the last three.

Details›
Price / booktoday's price, trailing year to Jun 30, 2026
1.87
EV / EBITtoday's price, trailing year to Jun 30, 2026
7.21
EV / salestoday's price, trailing year to Jun 30, 2026
0.61
Consumer Cyclical median P/E317 names
18.0
Specialty Retail median P/E25 names
22.8
Free cash flow, trailing twelve months
$241M
Market capitalisation93.6 million shares, counted Jul 30, 2026
$1.63B
3-year revenue growth
−0.36%
3-year free cash flow growth
+19%
What the market has paid for these earnings: 41 quarters of its own multiple × $1.92 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$14.66
Its own P/E history, median$16.24
Its own P/E history, upper quartile$19.99
52-week range$11.82 – $17.63
Today$17.41

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

What is it worth?

Today's price against what its own multiples, its cash flow and your growth assumption say it is worth.

Against its own past

Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.